Page last updated: 2024-10-28

guanethidine and Arterial Occlusive Diseases

guanethidine has been researched along with Arterial Occlusive Diseases in 7 studies

Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"The authors report a case of severe algodystrophy of the foot complicating a typical episode of algodystrophy of the knee, and which resulted in appearances of acute ischaemia of the foot."1.27[Severe algodystrophy of the foot simulating ischemic arteriopathy. Spectacular cure by regional sympathetic block with guanethidine]. ( Brunot, J; Clément, R; Doury, P; Eulry, F; Flageat, J; Metges, PJ; Pattin, S; Vasseur, P, 1987)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blunt, RJ1
Porter, JM1
Acevedo, A1
Procacci, P1
Zoppi, M1
Maresca, M1
Coffman, JD1
Muller, A1
Sudbrack, G1
Doury, P1
Pattin, S1
Eulry, F1
Vasseur, P1
Clément, R1
Metges, PJ1
Flageat, J1
Brunot, J1
Kubo, T1
Amano, H1
Katsumata, M1
Misu, Y1

Reviews

2 reviews available for guanethidine and Arterial Occlusive Diseases

ArticleYear
Raynaud syndrome.
    Seminars in arthritis and rheumatism, 1981, Volume: 10, Issue:4

    Topics: Adrenergic beta-Antagonists; Adult; Angiography; Antibodies, Antinuclear; Arterial Occlusive Disease

1981
Vasodilator drugs in peripheral vascular disease.
    American journal of hospital pharmacy, 1975, Volume: 32, Issue:12

    Topics: Arterial Occlusive Diseases; Cyclandelate; Ergot Alkaloids; Ethanol; Guanethidine; Humans; Ischemia;

1975

Other Studies

5 other studies available for guanethidine and Arterial Occlusive Diseases

ArticleYear
[Controlled circulatory blockade. Historical principles and future perspectives].
    Wiener medizinische Wochenschrift (1946), 1993, Volume: 143, Issue:7-8

    Topics: Anesthesia, Conduction; Arterial Occlusive Diseases; Guanethidine; Humans; Infusions, Intravenous; I

1993
[Guanethidine therapy of reflex sympathetic syndromes].
    La Clinica terapeutica, 1975, Jun-30, Volume: 73, Issue:6

    Topics: Adult; Aged; Arterial Occlusive Diseases; Causalgia; Drug Evaluation; Edema; Female; Fibromyalgia; G

1975
[Intravenous sympatholysis in arterial occlusive diseases and acrosyndromes].
    Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression, 1990, Volume: 31, Issue:4

    Topics: Arterial Occlusive Diseases; Bretylium Compounds; Guanethidine; Humans; Injections, Intravenous; Isc

1990
[Severe algodystrophy of the foot simulating ischemic arteriopathy. Spectacular cure by regional sympathetic block with guanethidine].
    Annales de medecine interne, 1987, Volume: 138, Issue:1

    Topics: Adult; Arterial Occlusive Diseases; Autonomic Nerve Block; Diagnosis, Differential; Female; Foot; Fo

1987
Involvement of central catecholamines in mediation of pressor responses of the rat to carotid occlusion.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 328, Issue:3

    Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Brain; Carotid Artery Diseases; Catecholamines

1985